Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Daewoong Co Ltd

+ Add to Watchlist

003090:KS

45,500 KRW 00.00%

As of 19:57:38 ET on 03/02/2015.

Snapshot for Daewoong Co Ltd (003090)

Open: 45,200 Day's Range: 45,150 - 45,500 Volume: 44
Previous Close: 45,500 52wk Range: 36,700 - 57,000 1-Yr Rtn: +14.72%

Stock Chart for 003090

No chart data available.
  • 003090:KS 45,500
  • 1D
  • 1M
  • 1Y
45,500
Interactive 003090 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 003090

Current P/E Ratio (ttm) 9.4477
Estimated P/E(-) -
Relative P/E vs. KOSPI 0.3165
Earnings Per Share (ttm) 4,816.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 529,092.02
Shares Outstanding (M) 11.63
30 Day Average Volume 2,962
Price/Book (mrq) 0.9676
Price/Sale (ttm) 0.4537
Dividend Indicated Gross Yield 1.10%
Cash Dividend (KRW) 500.0000
Dividend Ex-Date 12/27/2013
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 003090

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 003090

Daewoong Co., Ltd. is a investment holding company which operates biotechnology, marketing system, and healthcare entities. The Company also invests and develops over-the-counter drugs (OTC).

Yoon Young-HwanChairman/Co-Rep DirectorYoon Jae SeungVice Chairman/Co-Rep Director
Chung Nan-YoungPresident/Co-Rep DirectorChung Jong-GeunSenior Managing Director
More Company Profile & Key Executives for 003090

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil